The effects of dietary improvement on symptoms of depression and anxiety: a meta-analysis of randomized controlled trials
References Mazokopakis EE, Karefilakis CM, Starakis IK
These patients are seeing endocrinologists or primary care physicians, but many endocrinologists are prescribing the GLP-1 therapies, and theyre very adept at screening because of the concern thats been raised
M.HantelS.SalsaliA.et al (2016)
Liu Y, Tian Q, Yang J, Wang H, Hong T
Danish pharma major Novo Nordisk (NOV: N) late Thursday announced that the US Food and Drug Administration (FDA) has approved Wegovy HD (once-weekly injectable semaglutide 7.2mg) to reduce excess body weight and maintain weight reduction long-term